http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102234286-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc12f48618be8909d7af78e046b536b7
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-147
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-541
filingDate 2010-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0c51870024f4077e883d0994f5256b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34097f934799f889a0a55a610783d65b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46ee5e437e0eb75bf9e67719c02ce231
publicationDate 2011-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102234286-A
titleOfInvention Condensed heteroaryl derivatives
abstract The invention discloses condensed heteroaryl derivatives, and a preparation method and application thereof. The derivatives are phosphatidylinositol-3-kinase (PI3K) inhibitors, and have good PI3K inhibiting effect and cancer cell proliferation inhibiting effect, so that the condensed heteroaryl derivatives can be used for treating therapeutic agents for tumors.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10249827-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018135362-A
priorityDate 2010-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466140539

Total number of triples: 19.